H-FABP as a Biomarker in Transient Ischemic Attack
- PMID: 39160445
- DOI: 10.1007/s12265-024-10552-4
H-FABP as a Biomarker in Transient Ischemic Attack
Abstract
The study investigates the utility of heart fatty-acid binding protein (H-FABP) in distinguishing TIA from mimics. Data from 175 patients from the StrokeChip multicenter study was retrospectively analyzed. H-FABP level was measured using a rapid point-of-care test. Findings revealed that H-FABP levels were higher in individuals with TIA compared to mimics [3.10 ng/mL (IQR 2.13-4.78) vs. 1.70 ng/mL (IQR 1.23-2.38)] (p < 0.001). The diagnostic performance of H-FABP, assessed using the area under the curve operating characteristic curve (AUC) was 0. 83 (95% CI = 0.76-0.90) for the final model, indicating good discriminative ability. The PanelomiX determined that a combined cutoff of > 1.85 ng/ml for H-FABP, age > 42.5 years, and baseline NIHSS > 3.5 had a 100% of sensitivity and 23.30% of specificity. The study suggests that H-FABP has potential as a TIA diagnostic biomarker. The rapid application of POCT's for H-FABP measurement supports its potential use in emergency departments and primary care settings.
Keywords: Biomarker; Diagnostic; H-FABP; Ischemia; MIMIC; POCT; TIA.
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Ethical Approval: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study protocol was approved by the Hospital Vall d’Hebrón Ethics Committee. Informed Consent: All patients or their relatives signed informed consent. Conflicting Interests: The authors declare that there are no conflicts of interest.
References
-
- Díaz-Guzmán J, Egido J-A, Gabriel-Sánchez R, Barberá-Comes G, Fuentes-Gimeno B, Fernández-Pérez C, Group, on behalf of the I. S. I. of the S. P. of the S. C. D. S. Stroke and transient ischemic attack incidence rate in Spain: the IBERICTUS study. Cerebrovasc Dis. 2012;34(4):272–81. https://doi.org/10.1159/000342652 . - DOI
-
- The Burden of Stroke in Europe | The Burden of Stroke in Europe Report. 2017. Retrieved from https://strokeeurope.eu/index/the-burden-of-stroke-in-europe/ . Accessed 29 Aug 2022.
-
- Coutts SB. Diagnosis and management of transient ischemic attack. Continuum (Minneapolis, Minn). 2017;23(1, Cerebrovascular Disease):82–92. https://doi.org/10.1212/CON.0000000000000424 . - DOI - PubMed
-
- Chandratheva A, Mehta Z, Geraghty OC, Marquardt L, Rothwell PM. Population-based study of risk and predictors of stroke in the first few hours after a TIA. Neurology. 2009;72(22):1941–7. https://doi.org/10.1212/WNL.0b013e3181a826ad . - DOI - PMC - PubMed
-
- Francisco P, Joan M, Álex R, Pilar D, Manuel Q, José Á-S. Higher risk of further vascular events among transient ischemic attack patients with diffusion-weighted imaging acute ischemic lesions. Stroke. 2004;35(10):2313–9. https://doi.org/10.1161/01.STR.0000141703.21173.91 . - DOI
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous